Navigation Links
No Clear Winner in Diabetes Treatment Trial
Date:9/21/2007

e in the two- and three-times-a-day regimen had a down side, the team noted, since it was also accompanied by an increased incidence of weight gain and low blood sugar levels, the report said.

Still, the results indicated that "the best thing to be done is to follow current guidelines," McMahon said. That means "using long-acting drugs and adding insulin either once, twice or three times a day," he said, depending on each patient's particular needs.

What the new data "suggests to the doctor is that if you are serious about controlling diabetes, you should be willing to use the more complex method," added Dr. Larry Deeb, clinical professor of pediatrics at the University of Florida and immediate past president of the American Diabetes Association.

Diabetes control "is hard work for doctor and patient," Deeb said, and "family doctors have got to learn to give insulin the way we endocrinologists do." Deeb is located in Tallahassee, Fla., where the ratio of endocrinologists is 1 to 75,000 inhabitants, he noted.

Family doctors can handle type 2 diabetes, McMahon said, but it is best if they do not work alone. "An endocrinologist, nutritionist and nurse-educator should cooperate," he said.

Because type 2 diabetes is a major risk factor for heart disease, attention should be paid not only to blood sugar levels but also to other coronary risk factors, such as blood pressure and cholesterol levels, McMahon said.

What lies ahead for the British study is uncertain, McMahon said. "They are going to next look at what happens when the first steps fail," he said.

More information

For more on type 2 diabetes, consult the American Diabetes Association.



SOURCES: Graham T. McMahon, M.D., assistent professor, medicine, Brigham and Women's Hospital, Boston; Larry Deeb, M.D., clinical professo
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. British Doctor cleared of murder
3. Benefits of Vitamin Supplements Unclear
4. Chemicals in clear plastics can cause learning difficulties
5. Spray on contraceptive clears Phase I trial
6. Cancer risk among nuclear industry workers
7. Nuclear magnetic resonance spectroscopy aids in mapping protein structure
8. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
9. 21 Women With Breast Cancer Given All Clear By Radiologist
10. Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No
11. The Decks Cleared For HRT - Safe for Menopause Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...n. 8 New York City Mayor Michael R...Education Day" and presented a proclamation to Ilc...ucation Association) and developer of Brain Educat...to enhance health, well-being, and mental ability ... leader regarding the power of individuals to chan...
(Date:1/8/2009)...Va., Jan. 8 Today, the ...along with several national leadership organizatio...ciples of hospice care and protection of the Medic...gether in sharing this unified message about end-o...e and Palliative Medicine, Hospice and Palliative ...
(Date:1/8/2009)...ugar sitting on the surface of cancer cells are ke...th treating and stopping the spread of certain typ...state, breast, ovarian and lung, among others. Ar...e Gateway for Cancer Research, an Illinois-based p...ranco, M.D., Ph.D., and her co-workers at the Moor...
(Date:1/8/2009)...ts Prenatal Solution Key Factor in Decision for Fl...LANDO, Fla., Jan. 8 Alls...LC, one of the largest multi-specialty group pract...the Allscripts Enterprise(TM) Electronic Health Re...ians in 18 offices across Central Florida. , ,...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
...d test called Cystatin-C for predicting cardiovasc...malfunction. Earlier test that was used was creati...e more effective and better predictor than the ear...hree types of cardiovascular risks: low, medium an...
...erial infection of the lungs, says a study publish...rchers had studied persons of age between 2 to 49 ...rsons with invasive pneumococcal disease, 10 perso...as controls. Asthma was defined by the study as pr...
...ity Baptist Medical Center, US, have found that lo...hildren with cancer, and thus limits the side effe...oked into the chemotherapy given to children suffe...(ALL). Patients suffering from for this type of ch...
...accine for treating Alzheimer’s disease may be abl... use the bodies own immunity to resist the onset a...t affect people above the age of 40 years. The fi...ls which began some time back, was when scientists...
Other Medicine News:
(Date:1/7/2009)... , FREDERICK, Md., Jan. 7 ImQue...bmission of an IND application to the Food and Dru... for their lead pyrimidinedione HIV inhibitor IQP-... studies in the first quarter of 2009. IQP-0410 is...marily acts as a nonnucleoside reverse transcripta...
(Date:1/6/2009)... , Program Expands on Successful Results from p... Jan. 7 Vital Therapies, Inc. (VTI...ease, today announced patient enrollment has begun... 2 clinical trial that will study the Extracorpore...atients with Acute Liver Failure (ALF) under three...
(Date:1/6/2009)... , ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswir...utical company focused on diseases of epidemic pot...candidate for the treatment of tuberculosis (TB), ...wly awarded clinical program contract to Dynport V...e contract, awarded by the National Institute of A...
(Date:1/5/2009)... , SAN DIEGO, Jan. 5 Cylene Pha... a Phase I clinical trial of its oral CK2 protein ...ed solid tumors, Castleman,s disease, or multiple ...calating trial are determination of safety, tolera... appropriate dose for Phase II trials. In addition...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 1Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 2Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 4Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 1Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 2Immune System Works Better at Night 32164 1Immune System Works Better at Night 32164 2Later School Start Time Cuts Teens Car Crash Risk 32162 1Later School Start Time Cuts Teens Car Crash Risk 32162 2Later School Start Time Cuts Teens Car Crash Risk 32162 3
...)--Jun 4, 2007 - Introgen Therapeutics, Inc.,(NASD... today,reported updated Phase 2 data demonstrating...umor responses and increased,survival following AD...us cell carcinoma of the head and neck. The data (... meeting of the American,Society of Clinical Oncol...
...se 2 Clinical Data Published at the American,Socie...GO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmi...m its Phase II,multi-center clinical study of Amr...nthracycline currently in development,for the trea...dicate favorable interim results in terms of respo...
Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: